Simplex Trading, LLC G1 Therapeutics, Inc. Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	BUY	$1.12 - $3.73 $242,083 - $806,224	216,146 Added 1236.53%	233,626 $712,000
Q3 2023 Nov 01, 2023	BUY	$1.22 - $2.67 $21,325 - $46,671	17,480 New	17,480 $25,000
Q4 2022 Feb 02, 2023	SELL	$5.19 - $13.5 $51,925 - $135,067	-10,005 Reduced 51.31%	9,496 $51,000
Q3 2022 Nov 04, 2022	BUY	$5.17 - $16.99 $100,820 - $331,321	19,501 New	19,501 $243,000
Q1 2022 May 02, 2022	SELL	$7.6 - $11.02 $28,241 - $40,950	-3,716 Closed	0 $0
Q4 2021 Feb 23, 2022	BUY	$10.16 - $16.17 $29,789 - $47,410	2,932 Added 373.98%	3,716 $37,000
Q3 2021 Oct 28, 2021	BUY	$13.16 - $22.47 $684 - $1,168	52 Added 7.1%	784 $17,000
Q2 2021 Aug 12, 2021	SELL	$19.57 - $26.32 $436,528 - $587,093	-22,306 Reduced 96.82%	732 $16,000
Q1 2021 Apr 26, 2021	SELL	$17.58 - $32.59 $60,791 - $112,696	-3,458 Reduced 13.05%	23,038 $554,000
Q4 2020 Feb 02, 2021	BUY	$10.99 - $20.4 $289,476 - $537,336	26,340 Added 16884.62%	26,496 $476,000
Q3 2020 Oct 14, 2020	SELL	$11.55 - $23.75 $1,951 - $4,013	-169 Reduced 52.0%	156 $1,000
Q2 2020 Jul 13, 2020	BUY	$9.57 - $24.37 $3,110 - $7,920	325 New	325 $7,000
Q1 2020 Apr 29, 2020	SELL	$9.07 - $26.32 $1,786 - $5,185	-197 Closed	0 $0
Q4 2019 Feb 05, 2020	SELL	$20.54 - $31.0 $18,691 - $28,210	-910 Reduced 82.2%	197 $5,000
Q3 2019 Oct 15, 2019	BUY	$22.78 - $40.58 $23,713 - $42,243	1,041 Added 1577.27%	1,107 $25,000
Q2 2019 Jul 26, 2019	BUY	$16.03 - $31.1 $1,057 - $2,052	66 New	66 $2,000
Q1 2019 Apr 18, 2019	SELL	$14.4 - $21.45 $1,440 - $2,145	-100 Closed	0 $0
Q4 2018 Jan 16, 2019	BUY	$16.51 - $51.33 $1,651 - $5,133	100 New	100 $1,000

Others Institutions Holding GTHX

# of Institutions

Shares Held

3.55M

Call Options Held

11.7K

Put Options Held

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account